Applications are now open for the latest round of the Michael G. DeGroote Fellowship Awards. The application deadline is April 1, 2023.
The DeGroote Fellowship Awards are offered in TWO categories:
1) The Michael G. DeGroote Fellowship Award in Basic Biomedical Science. Candidates conducting basic science research will be eligible for the Basic Biomedical Science Fellowship Award
2) The Michael G. DeGroote Fellowship Award in Clinical Research. Candidates pursuing clinical research will be eligible for the Clinical Research Fellowship Award.
Applicants must identify in their application which award they are applying for. Separate selection committees review the respective applicants for each award.
What are the Michael G. DeGroote Fellowship Awards?
The prestigious Michael G. DeGroote Fellowship Awards provide postdoctoral candidates in the Faculty of Health Sciences the opportunity to pursue leading-edge health sciences research.
The awards are designed for candidates who have an exemplary academic record and are interested in pursuing postdoctoral work in one of the numerous areas of research excellence in the Faculty of Health Sciences at McMaster University. Funded through the generosity of Michael G. DeGroote, the award will provide support of $40,000 for one year. This amount is to be supplemented with $10,000 from applicants’ proposed supervisor(s), for a total annual amount of $50,000 for one year.
Successful candidates for these awards will have the opportunity to work with Health Sciences faculty who are conducting innovative research and are considered among the best in their fields. They will have access to state-of-the-art facilities that enable progressive research designed to impact health care throughout the world.
Eligibility
Please note that candidates must fulfill or have fulfilled all degree requirements for a PhD, PhD-equivalent or health professional degree in order to be eligible for these awards.
To be eligible for this program, you must have started your postdoctoral or health professional degree studies on, or after, July 1, 2022. Additionally, eligible candidates must be within five years of receiving their PhD or MD. Individuals who completed post-doctoral studies or a fellowship at McMaster under a different supervisor are not eligible.
The candidate must plan to conduct their research in a department or school (or related centre or institute) that resides in the Faculty of Health Sciences at McMaster University.
For candidates who hold (or are completing) a PhD, the proposed supervisor(s) listed in your application must be different than your PhD supervisor. Your proposed supervisor must be from within the Faculty of Health Sciences, but you could have a co-supervisor that is from another Faculty.
Priority will be given to those applicants whose graduate training has not been exclusively at McMaster.
News
Meet the seven McMaster researchers conducting pioneering research supported by significant federal funding
Seven projects led by Faculty of Health Sciences (FHS) researchers received $61 million from the Canadian Institutes of Health Research (CIHR) to advance medical research, training and innovation.
The funding was announced on Jan. 19 at McMaster University by Filomena Tassi, MP for Hamilton West-Ancaster-Dundas and minister responsible for the Federal Economic Development Agency for Southern Ontario, as part of CIHR’s Clinical Trials funding initiative.
The stories on all seven FHS research projects can be found here:
Deborah Cook received an additional $1.9 million for an ongoing global trial to test the effectiveness of an ulcer-suppressing drug in patients in the intensive care unit.
P.J. Devereaux, co-lead for the Pan-Canadian Accelerating Clinical Trials Consortium, received $39 million to expand its clinical trial networks, support clinical trial units and improve collaboration and knowledge sharing.
Kim Lewis received $3.7 million for an international pragmatic randomized control trial focused on non-invasive ventilation in the critically ill.
Sameer Parpia received more than $2.5 million in federal funding to help plug a critical shortage of clinical trial biostatisticians using a Canada-wide training platform.
Jason Roberts is tackling a lethal genetic heart condition with a potentially revolutionary treatment, helped by $2.7 million in funding.
Bram Rochwerg received $3.4 million to test a potentially life-saving therapy for people experiencing acute breathing difficulty.
Fiona Smaill received $8.2 million for Phase 2 human trials to evaluate the safety and efficacy of a next-generation COVID-19 vaccine delivered by inhaled aerosol.
The Brighter World story of the announcement itself can be found here.
/general-use/logos/external-group-logos/news-aoda.jpg?sfvrsn=f93f9048_2)